Apellis Pharmaceuticals (NASDAQ:APLS) Announces Quarterly Earnings Results, Meets Estimates theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Apellis Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:APLS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CFO Timothy Eugene Sullivan sold 4,000 shares of Apellis Pharmaceuticals stock in a transaction on Monday, April 1st. The stock was sold at an average price of $58.66, for a total transaction of $234,640.00. Following the sale, the chief financial officer now directly owns 93,338 shares of […]
Apellis Pharmaceuticals (NASDAQ:APLS) Stock Rating Reaffirmed by Mizuho themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Covestor Ltd raised its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 564.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 797 shares of the company’s stock after purchasing an additional 677 shares during the period. Covestor Ltd’s holdings in Apellis […]